Validation and Reproducibility of S.P.A.T. With Allergens
1 other identifier
interventional
112
1 country
1
Brief Summary
To improve accuracy and take out human error opportunities, Hippo Dx developed S.P.A.T., an automated skin prick test. This study will provide a comparison between manual and automated skin prick test in allergic and non-allergic individuals with a panel of common inhalant allergens. The primary endpoint is to compare the accuracy of S.P.A.T. to detect sensitization to common aeroallergens compared to a manual skin prick test (SPT). It is a prospective monocentric study that will include 120 study participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2023
CompletedStudy Start
First participant enrolled
March 18, 2023
CompletedFirst Posted
Study publicly available on registry
April 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedFebruary 28, 2024
July 1, 2023
1 month
January 30, 2023
February 27, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Within-test agreement (% of patients with consistent results) of wheal positivity per allergen between manual and automated test.
Each of the allergens are pricked three times via manual and automated skin prick test. Three positive or negative test results are considered consistent whereas either one or two positive or negative test results are considered non-consistent resulting in an inconclusive test result.
15 minutes after the diagnostic test
Secondary Outcomes (4)
Allergy symptoms assessed by visual analogue scale between patients with a positive versus negative test result.
day of the diagnostic test
Time (seconds) required to run an automated versus a manual skin prick test.
during the diagnostic test
Amount of allergen solution that is required to run an automated versus a manual skin prick test.
during the diagnostic test
Level of discomfort experienced by the patient as assessed by visual analogue scale after an automated versus a manual skin prick test.
15 minutes after the diagnostic test
Study Arms (1)
Skin Prick Test
OTHERStudy participants will receive a skin prick test by the skin prick automated test device on the right arm and manually by a health care provider on the left arm.
Interventions
skin prick test to detection sensitisation to aeroallergens
skin prick test to detection sensitisation to aeroallergens
Eligibility Criteria
You may qualify if:
- Adults (18-65y) with presence or absence of self-reported symptoms of inhalant allergy will be included.
You may not qualify if:
- Skin pathology like chronic or exuberant urticaria, dermographism, chronic dermatitis that needs daily treatment
- Use of antihistaminic medication \< 7 days before the start of the study
- Use of tricyclic antidepressants (antihistamine activity) \< 7 days before the start of the study
- Use of topical corticoids on the forearm \< 7 days before the start of the study
- Use of Omalizumab \< 6 months before the start of the study
- Pregnancy: there is a remote possibility of inducing a systemic allergic reaction that could induce uterine contractions or necessitate the use of epinephrine (thought to cause constriction of the umbilical artery)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hippocreateslead
Study Sites (1)
AZ Herentals
Herentals, 2200, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hendrik Sebrechts, MD
AZ Herentals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2023
First Posted
April 21, 2023
Study Start
March 18, 2023
Primary Completion
April 30, 2023
Study Completion
June 30, 2023
Last Updated
February 28, 2024
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share